Literature DB >> 3128476

Clostridium difficile toxins A and B inhibit human immune response in vitro.

W Däubener1, E Leiser, C von Eichel-Streiber, U Hadding.   

Abstract

Two Clostridium difficile toxins isolated from strain VPI 10463 were tested for their effect on different human T-cell proliferation systems. In mitogen- and antigen-driven T-cell proliferation systems, toxins inhibited the proliferative response in a dose-dependent fashion. In interleukin-2-driven culture systems, no effect of toxins could be found on preactivated T cells. We suspected that monocytes were the influenced cells, since in antigen- and mitogen-driven systems monocytes were necessary for the proliferative response, whereas the interleukin-2-driven system was independent of monocytes. To prove this concept, purified monocytes were treated with toxins. The treatment was found to markedly reduce the capacity of monocytes to stimulate T-cell proliferation. No inhibition of the proliferative response was measured when, instead of monocytes, resting or preactivated T cells were treated with toxins. These experiments clearly show that C. difficile toxins interact with monocytes and not with T cells. The effect of toxins on cells of the immune system might be one factor in the development of pseudomembranous colitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128476      PMCID: PMC259770          DOI: 10.1128/iai.56.5.1107-1112.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Clindamycin-associated colitis.

Authors:  L E Cohen; C J McNeill; R F Wells
Journal:  JAMA       Date:  1973-03-19       Impact factor: 56.272

3.  Biochemical studies on the effect of Clostridium difficile toxin B on actin in vivo and in vitro.

Authors:  M J Mitchell; B E Laughon; S Lin
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  Biological activities of toxins A and B of Clostridium difficile.

Authors:  D M Lyerly; D E Lockwood; S H Richardson; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Purification and characterization of toxins A and B of Clostridium difficile.

Authors:  N M Sullivan; S Pellett; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Effects of Clostridium difficile toxin on tissue-cultured cells.

Authors:  S T Donta; S J Shaffer
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

Review 7.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

8.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

9.  Morphologic and functional effects of Clostridium difficile enterotoxin in tissue culture.

Authors:  M J Gurwith; C Langston; B Dunsmore
Journal:  Can J Microbiol       Date:  1982-01       Impact factor: 2.419

10.  Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture.

Authors:  M Thelestam; M Brönnegård
Journal:  Scand J Infect Dis Suppl       Date:  1980
View more
  9 in total

1.  Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.

Authors:  F Müller; C Stiegler; U Hadding
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

2.  Comparative sequence analysis of the Clostridium difficile toxins A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Mol Gen Genet       Date:  1992-05

3.  Effects of toxin A from Clostridium difficile on mast cell activation and survival.

Authors:  G M Calderón; J Torres-López; T J Lin; B Chavez; M Hernández; O Muñoz; A D Befus; J A Enciso
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication.

Authors:  Elaine E Hamm; Daniel E Voth; Jimmy D Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

5.  Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

6.  Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward.

Authors:  A H Gifford; K B Kirkland
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

7.  Immune suppressive effects of Helicobacter pylori on human peripheral blood mononuclear cells.

Authors:  U Knipp; S Birkholz; W Kaup; W Opferkuch
Journal:  Med Microbiol Immunol       Date:  1993-05       Impact factor: 3.402

8.  Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.

Authors:  W A Flegel; F Müller; W Däubener; H G Fischer; U Hadding; H Northoff
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

Review 9.  Toxins-useful biochemical tools for leukocyte research.

Authors:  Susana Cubillos; Johannes Norgauer; Katja Lehmann
Journal:  Toxins (Basel)       Date:  2010-03-26       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.